Optimisation and validation of hydrogel-based brain tissue clearing shows uniform expansion across anatomical regions and spatial scales by Tyson, AL et al.
1Scientific RepoRtS |         (2019) 9:12084  | https://doi.org/10.1038/s41598-019-48460-2
www.nature.com/scientificreports
optimisation and validation 
of hydrogel-based brain tissue 
clearing shows uniform expansion 
across anatomical regions and 
spatial scales
Adam L. tyson 1,2,3, Ayesha M. Akhtar1 & Laura c. Andreae  1,2
Imaging of fixed tissue is routine in experimental neuroscience, but is limited by the depth of tissue 
that can be imaged using conventional methods. optical clearing of brain tissue using hydrogel-
based methods (e.g. cLARitY) allows imaging of large volumes of tissue and is rapidly becoming 
commonplace in the field. However, these methods suffer from a lack of standardized protocols and 
validation of the effect they have upon tissue morphology. We present a simple and reliable protocol for 
tissue clearing along with a quantitative assessment of the effect of tissue clearing upon morphology. 
Tissue clearing caused tissue swelling (compared to conventional methods), but this swelling was 
shown to be similar across spatial scales and the variation was within limits acceptable to the field. The 
results of many studies rely upon an assumption of uniformity in tissue swelling, and by demonstrating 
this quantitatively, research using these methods can be interpreted more reliably.
Fluorescence microscopy of fixed tissue sections is widely used in neuroscience, and biomedical science generally. 
However, light absorption (due to pigmentation) and scatter (due to heterogeneous refractive index (RI) of the 
tissue) limit the depth of tissue that can be imaged. To overcome this, tissue is usually sliced into thin sections 
(100 μm or less) which is laborious, and can introduce artefacts if large volumes of tissue are studied.
Light scatter due to lipid content is the predominant mechanism preventing deep imaging in brain tissue, and 
so tissue-processing methods have been developed to homogenise the RI of the tissue and reduce scatter. These 
methods are collectively known as tissue clearing, and were originally proposed a century ago1. More recently, 
the idea of tissue clearing for large-volume microscopy has been revisited. These methods have used different 
approaches, such as immersion in RI matching solutions2–8, the use of organic solvents9–15 and the direct removal 
of tissue lipids16–20. Of these, the methods relying on lipid removal, and particularly hydrogel-based methods (e.g. 
CLARITY17) have been those most adopted by the research community.
Hydrogel-based tissue clearing methods have so far been popular due to their reliability and flexibility (as 
they are one of the clearing methods compatible with antibody staining). Many variations on these methods have 
been published17,21–27 but they all share a general core concept. Firstly, the tissue is incubated in a fixative solution 
containing paraformaldehyde (PFA) and acrylamide (with or without bis-acrylamide). This fixative binds bio-
molecules containing an amine group (chiefly proteins and nucleic acids) but not membrane phospholipids, and 
is then polymerised to to form a transparent hydrogel ‘matrix’ within the tissue. As the majority of lipids are not 
bound to this matrix, they can then be removed by using a detergent solution of sodium dodecyl sulfate (SDS) 
along with a combination of heat and electrophoresis or mechanical agitation to accelerate the process. Once the 
sample’s RI is matched using a high RI solution, the final result is a transparent and macromolecule permeable 
sample in which most protein and nucleic acid is preserved17,21,27–29.
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There have been tremendous advances in tissue clearing along with imaging and analysis of large volumes of 
brain tissue. However, because these methods are not as mature as traditional methods (e.g. thin-section immu-
nohistochemistry), two issues remain. The first is choosing an experimental protocol — there are many param-
eters to choose to ensure effective tissue clearing and staining. The second, and most important, is validation 
— these methods are starting to become routine, and yet there is very little information about how these methods 
affect tissue morphology.
Here we present an optimisation of a hydrogel-based tissue clearing and antibody staining protocol in adult 
mouse brain tissue. This was chosen as it is the most common, and most flexible use of tissue clearing in neuro-
science. In addition, a detailed analysis was performed, comparing tissue morphology in cleared tissue to tissue 
processed using a more conventional method.
Results
tissue clearing. To fully optimise hydrogel-based clearing of brain tissue, a number of parameters from 
the original report17 were varied. Samples were incubated whole, in hemispheres, or in slices taken using a brain 
slicing matrix30 and at room temperature or 37 °C with or without shaking in clearing buffer (4% or 8% SDS) to 
clear. Clearing buffers were changed weekly, until the sample appeared visibly clear (i.e. until the tissue does not 
obscure printed structures underneath, Fig. 1B).
All tissue samples, regardless of sample size cleared successfully, showing little light scatter despite some dis-
colouration (Fig. 1B). Large volumes of brain tissue (e.g. whole, adult mouse brains, Fig. 1C) could be cleared, 
despite more discolouration and scatter. A number of hydrogel compositions were tested (Table 1). The specific 
combinations were chosen based on those used successfully in the literature17,21,22, and acrylamide/PFA concen-
tration was varied together to avoid the need to test the large number of combinatorial options. We found that 
shaking at 37 °C was required for complete, uniform clearance, but that hydrogel composition or SDS concen-
tration did not subjectively affect the quality of the cleared tissue. We did however find that an increase in SDS 
concentration (from 4% to 8%) slightly increased the speed of tissue clearing, and that hydrogel composition 
affected clearing times more substantially. The original hydrogel composition (A4B5P4) allowed 2 mm slices 
to clear in 5 weeks and whole adult mouse brains to clear in approximately 15 weeks. However, samples cleared 
much faster when prepared with hydrogel containing lower PFA and acrylamide concentrations (Table 1). The 
definition of “clear” is experiment specific because the amount of acceptable scatter depends on the brightness of 
the fluorescent probe, the resolution needed, and the microscope modality. For this reason, the results in Table 1 
were not repeated, and are intended as a guide. All hydrogel compositions allowed for successful staining, and 
so subjectively, hydrogel composition does not appear to affect antigen preservation. However, tissue rigidity is 
affected, and care must be taken not to damage samples prepared with low-acrylamide hydrogel.
tissue staining. Antibody staining. Following tissue clearing, a number of different antibodies (Fig. 2, 
Supplementary Table 2) were tested, related to a variety of aspects of brain structure. Markers included cortical 
layer markers, striatal cell markers, inhibitory interneurons, synaptic markers, white matter markers and general 
cell type markers. Of these antibodies, eight produced reliable staining. These included the neuronal cell type 
Figure 1. Mouse brain tissue incubated in hydrogel (A4B5P4), cleared using SDS and RI matched using 85% 








Time taken for 
clearance [weeks]
A4B0P0 4 0.00 0 3
A1B5P1 1 0.05 1 5
A2B5P2 2 0.05 2 6
A4B5P4 4 0.05 4 12
Table 1. Time taken to clear mouse brain hemispheres prepared with different hydrogel concentrations.
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markers CTIP2, CUX1, calbindin and parvalbumin along with the stains for neuronal projections (MBP and 
neurofilament) and general neuronal (NeuN) and astrocyte (GFAP) markers.
All appropriate secondary antibodies (Supplementary Table 3) tested worked well, and so it is thought that 
only the primary antibody choice is critical in cleared tissue.
Antibody penetration. To assess how much time antibodies took to diffuse into cleared tissue, the diffusion of 
the calbindin (rabbit) antibody was tested in mouse cortex (hydrogel composition — A4B5P4). This antibody 
was chosen as the protein is expressed relatively evenly across the cortex without being too dense (unlike neuro-
filament for example). Dense protein expression would complicate analysis, as antibody depletion would become 
the main factor limiting staining depth, rather than diffusion speed. To determine the speed of staining, the 
antibody incubation time (for primary and secondary antibody) was varied, and the staining depth (the distance 
into the tissue at which brightly positive cells could be seen) was measured. To ensure that differences in the level 
of tissue clearance did not affect antibody penetration, this was repeated in different sections of the same mouse 
brain, all the same thickness (1.5 mm), and cleared for the same length of time (3 weeks). Samples were incubated 
in antibody solutions for 1, 3, 7 or 11 days, and antibody penetration was measured. This was measured in four 
different cerebral cortical areas spread across each tissue section. Measurements were taken in deep cortical lay-
ers (to prevent any contribution of antibody diffusing from the cortical surface). The mean was taken, and this is 
plotted in Fig. 3.
Small molecule stains. Due to the slow diffusion of antibodies into cleared brain tissue, low molecular weight, 
non-antibody based fluorescent stains were investigated. These stains could all be used to successfully stain an 
entire, intact mouse brain within 24 hours (e.g. Supplementary Fig. 1), and as such greatly increase the flexibility 
of hydrogel-based tissue clearing. These dyes included nucleic acid, Nissl and myelin stains (Fig. 4, Supplementary 
Table 4).
Comparison to conventional fixation. One potential issue with hydrogel-based tissue clearing tech-
niques is the expansion of the tissue that has been observed31. Although referenced in the literature, this tissue 
expansion has not been investigated in detail. All tissue processing techniques will affect brain structure in some 
way, and so tissue expansion is not necessarily a problem, as long as this tissue expansion is uniform across differ-
ent brain areas and different spatial scales.
To investigate the effects of tissue clearing, cleared tissue was compared to that fixed only using PFA and not 
cleared. Two adult, female littermate mice were perfused with phosphate buffered saline (PBS) and 4% PFA. One 
brain was post-fixed in hydrogel, before both brains were cut into 500 μm coronal sections and the hydrogel-fixed 
tissue was cleared. Following clearing, the cleared tissue and uncleared were treated identically and stained for a 
selection of markers. It is not possible to measure every possible brain structural parameter in every brain area, 
and so initially two anatomical markers in two brain regions were investigated. The cerebral cortex and striatum 
were investigated because of their very different structure, and how this could affect structure following clearing. 
Figure 2. Examples of successful antibody stains in mouse brain tissue. Scale bars 100 μm. (A) CTIP2 
staining of striatal spiny projection neurons, (B) CUX1 staining of layer II–IV cortical projection neurons, (C) 
Calbindin staining in olfactory bulb glomerular layer, (D) Parvalbumin staining of primary somatosensory 
cortical interneurons, (E) Neurofilament staining of striatal white matter tracts, (F) GFAP staining of cerebellar 
Bergmann glia, (G) NeuN staining in somatosensory cortex, (H) MBP staining of striatal white matter tracts.
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The striatum contains large numbers of myelinated fibre tracts (Fig. 2H) which have a very high lipid content. The 
lipid removal process (which is key to hydrogel-based tissue clearing) could therefore have a differential effect 
upon the striatum compared to the cortex which has a lower lipid content. The markers chosen were the antibody 
stains CTIP2 and parvalbumin. These were chosen because they are expressed densely in both areas, mark dif-
ferent cell types and because they allow the measurement of two key parts of tissue microstructure which may be 
affected differentially – nuclear volume (CTIP2) and whole-cell volume (parvalbumin).
Two-dimensional (2D) images were acquired across the cortex (primary motor cortex and barrel cortex) and 
striatum to compare the cell density of CTIP2- and parvalbumin-positive cells. Two cleared and two uncleared 
slices (each pair from a single brain) were imaged for each cell type in each brain area, with 80 images taken 
of cortical parvalbumin-positive cells (40 cleared and 40 uncleared), and 40 images taken of each cortical 
CTIP2-positive cells, striatal CTIP2- and striatal parvalbumin-positive cells. In all cases, the cell density was 
lower in cleared than uncleared tissue (p < 0.001, Fig. 5), suggesting tissue expansion. Although it is possible that 
the same results could occur owing to reduced antibody staining efficiency, this was thought to be unlikely, as the 
staining intensity of the positive cells was comparable between groups.
Figure 3. Antibody penetration depth as a function of incubation time (equal for primary and secondary 
antibodies), fitted with an exponential . − . − .e(0 8 0 8 )x0 38 .
Figure 4. Other fluorescent stains in mouse brain tissue. All in primary somatosensory cortex and scale bars 
100 μm other than fluromyelin (cortex and striatum scale bar 1 mm). (A) DAPI, (B) Propidium iodide, (C) 
SYTOX green, (D) SYTOX red, (E) Neurotrace red, (F) Fluromyelin green.
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To better understand whether these results were simply due to tissue expansion, and to assess whether this 
expansion occurred at different spatial scales, the volume of CTIP2-positive nuclei and parvalbumin-positive cells 
was investigated. The cell density result could have occurred due to uniform tissue expansion, or just expansion of 
the extracellular space. As before, two cleared sections and two uncleared sections were imaged for each cell type 
and each brain area. 30 cells in cleared tissue and 30 in uncleared tissue were imaged in three-dimensions (3D) 
for each cell type in each brain area, and the volumes (following manual segmentation) were compared between 
cleared and uncleared cells. In all cases, the cell volume was higher in cleared than in uncleared tissue (p < 0.001, 
Fig. 6).
An increase in cell volume alongside a decrease in cell density suggested that the findings were due to general 
tissue expansion that is uniform at different spatial scales. It was not possible to accurately measure the overall 
expansion of the brain due to small amounts of clearing-induced tissue deformation and tissue loss, and so DAPI 
staining was used to measure cortical thickness. Cortical thickness was measured in two areas (primary motor 
cortex and barrel cortex) in nine brain hemispheres in each group (cleared and uncleared). The cortices of cleared 
tissue were thicker in both motor cortex (p = 0.003) and barrel cortex (p = 0.001, Fig. 7), providing further evi-
dence for general tissue expansion as the cause for the increased cell volume and reduced cell density.
Figures 5–7 appear to show that tissue expansion affects all the measures in a similar fashion. These techniques 
are used under the assumption that any effects they have upon tissue structure are uniform across spatial scales 
and that no brain area or cell type is differentially affected. To assess whether this was the case, the variation in 
the effect of clearing upon the different parameters discussed above was calculated. Firstly, the relative change in 
the mean of each parameter was calculated, to give a measure of the expansion (Table 2). For volume or thickness 
measurements this was calculated as the cleared value divided by the uncleared value, and the inverse for the 
density measurements. This measure was then normalised to expansion in one dimension, so the 2D density 
measures were square-rooted, and the 3D volume measurements were cube-rooted. This normalised expansion 
metric is termed the “adjusted expansion ratio”.
This adjusted expansion ratio seems relatively similar (between 1.08 and 1.42) for all measures, but this does 
not give us any quantitative measure. To begin to understand whether the adjusted ratios are similar, and there-
fore whether the tissue expansion was uniform across these measures, the coefficient of variance (CV, ratio of the 
standard deviation to the mean) of these measures was then calculated from the adjusted expansion ratio. This 
measure, which we term the “clearing CV” is a single value which summarises how similar all of the adjusted 
expansion ratios are. If it is low, then clearing affected all the measures similarly (and tissue expansion can be 
Figure 5. Cell counts of CTIP2- and parvalbumin-positive cells in cortex and striatum, comparison between 
uncleared and cleared mouse brain tissue. Mean shown as a horizontal line.
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thought of as uniform). If it is high, then the measures are affected very differently, and the tissue clearing must 
affect these measures in different ways.
Unfortunately, the nature of CVs is that there is no “rule of thumb” about what variance is high, low, acceptable 
or unacceptable. Therefore we sought to develop a cut off, a CV threshold that would tell us whether our clearing 
CV was low enough to be acceptable. In our experiment, we defined acceptable levels of variance to be that of 
each of the individual measures in uncleared tissue. DAPI and antibody staining in conventionally-prepared 
tissue is thought to be reliable enough that it does not introduce large amounts of variance. These techniques 
are used routinely in the field, and any variance they introduce is not required to be measured or explained 
when publishing work based on these methods. Measures of variance (in neuroscience) are usually carried out to 
understand the differences between experimental subjects, and the variance introduced by standard techniques 
such as immunohistochemistry is assumed to be low enough that it does not affect the outcomes of the study. We 
Figure 6. Volumes of CTIP2- and parvalbumin-positive cells in cortex and striatum, comparison between 
uncleared and cleared mouse brain tissue. Mean shown as a horizontal line.
Figure 7. Comparison of cortical thickness in cleared and uncleared tissue, in motor and barrel cortices. Mean 
shown as a horizontal line.
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therefore propose that the variance of the measures in Figs 5–7 in conventionally prepared tissue (i.e. uncleared) 
in a single animal (removing any subject to subject variance) would give us an estimate (for this work at least) of 
what is “acceptable” variance. If the clearing CV (the variance introduced by clearing) is of a similar magnitude 
to the mean CV of each of these “standard” anatomical measures, then the variance introduced by clearing can be 
thought of as acting uniformly in different brain areas, and at different spatial scales.
The clearing CV for tissue expansion was 0.110, which was lower than the CV for all the measures in uncleared 
tissue other than cortical thickness (0.104 & 0.027), as shown in Fig. 8. The mean CV for all of the measures in 
uncleared tissue was 0.173, considerably higher than the clearing CV. This approach is novel, and does not prove 
that clearing affects each metric uniformly, but it suggests that the clearing CV is similar to generally accepted 
variance in the field. Showing that the variance introduced by clearing is lower than variance which is routinely 
accepted in the field, goes some way to showing that the tissue expansion introduced by clearing is relatively uni-
form, and may eventually not need to be considered (as long as the proper controls are performed).
Discussion
Hydrogel-based tissue clearing is a very reliable method, but one issue is compatibility with antibody staining. 
We found that out of 22 antibodies tested, only eight were successful. However, these eight were very reliable and 
are likely to be of great use in the neuroscience community. The clearing process is a very harsh one which may 
cause antigen damage and prevent antibody staining, but this does not explain why some antibodies worked and 
not others. There is no obvious common feature of the successful antibodies, and this remains something to be 
studied further.
Another issue with antibody staining is the time taken for uniform staining with high signal-to-noise (SNR). 
Conventional primary and secondary antibody technology is not suitable for diffusion through large volumes 
of tissue. There are many ways to potentially speed this up, but possibly at the expense of SNR or tissue damage. 
These methods include using fluorophore-conjugated primary antibodies, low molecular weight single-domain 
antibodies32 or the use of electric fields to accelerate diffusion33,34. Currently, none of these solutions are commer-
cially available for most antibodies, and so researchers must rely on long incubation times of antibodies which 





Cortical CTIP2 1.83 1.35
Cortical Parvalbumin 2.02 1.42
Striatal CTIP2 1.21 1.10
Striatal Parvalbumin 2.00 1.41
Cell volume
Cortical CTIP2 1.68 1.19
Cortical Parvalbumin 1.43 1.13
Striatal CTIP2 1.42 1.12
Striatal Parvalbumin 1.46 1.13
Cortical thickness
Motor cortex 1.14 1.14
Barrel cortex 1.08 1.08
Table 2. Relative and adjusted expansion ratios for each individual measure comparing uncleared and cleared 
tissue.
Figure 8. CVs for each measure in uncleared tissue with the CV due to clearing overlaid.
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The success of every small-molecule dye tested is potentially very useful. Cell nuclei stains have been used in 
conjunction with tissue clearing, but the Nissl and myelin stains have not yet (to our knowledge) been applied 
outside of method development. These stains can be used to stain much larger volumes of tissue than antibodies, 
and are much cheaper and easier to use. They are less specific than antibody stains, but in large tissue volumes 
they represent a great increase in specificity and resolution compared to competing techniques (e.g. magnetic 
resonance imaging).
We compared the variance of clearing-induced tissue expansion to acceptable levels of variance in the field. 
This approach was used due to a lack of standard statistical tests for this kind of work. While this does not prove 
that the tissue expansion is uniform, it does provide some sense of how uniform it is, and whether the variance 
introduced is low enough to not affect any biological conclusions. The variability of tissue expansion upon differ-
ent measures in different brain areas is generally less than the natural variability associated with these measures 
in uncleared tissue. For this reason, it is not thought that tissue clearing will introduce any biases that could affect 
the interpretation of any results. It is also well known that many tissue fixatives (including PFA) can shrink brain 
tissue considerably35, so it may be that the swelling introduced by clearing compared to PFA-only fixation may 
return the tissue closer to the structure found in vivo.
Since the original description of hydrogel-based tissue clearing17, there have been close to a hundred publica-
tions applying and extending the method36, the majority of them in neuroscience. We have described a simple and 
reliable protocol allowing investigation of many common neuroanatomical features including cell densities, white 
matter and glial structure along with the morphology of a number of specific cell types. Very few of the existing 
papers have measured the effect upon morphology of these techniques, other than just describing tissue expan-
sion very broadly. We have shown that although these methods do cause tissue expansion (at least compared to 
existing techniques), it can be thought of as happening relatively uniformly across spatial scales. Therefore as long 
as these methods are applied consistently, the results from them can be interpreted as reliably as with other, more 
established methods.
Methods
All procedures were performed under local King’s College London Animal Welfare and Ethical Review Body 
approval and under UK Home Office project and personal licenses, where necessary, in accordance with the 
Animals (Scientific Procedures) Act 1986. All chemicals used are listed in Supplementary Table 1.
tissue clearing. C57BL/6J mice were euthanised by cervical dislocation, and brain tissue was rapidly dis-
sected and incubated in ice-cold hydrogel solution. Hydrogel solutions were made up in PBS with 0.25% VA-044 
photoinitiator (Wako Chemicals GmbH, DE) according to Table 1.
Samples were incubated in hydrogel solution (with gentle shaking) at 4 °C for one week. To prevent inhibition 
of the polymerisation by oxygen, the samples were degassed using nitrogen17. This process involves setting up a 
vacuum gas manifold connected to a vacuum desiccator. A tube containing the sample in hydrogel solution is 
held under strong vacuum for 10 minutes, before flushing the tube with oxygen-free nitrogen gas. This is repeated 
and then the tube is closed as quickly as possible to prevent any oxygen entering the tube.
The sample tube (with hydrogel solution) was then polymerised in a 37 °C water bath for 3 hours. It is recom-
mended to use as large a water bath as possible, and to not use an incubator because the temperature and duration 
of polymerisation appear to have an effect upon the extent of polymerisation and eventual speed of tissue clearing 
and staining.
Once polymerisation is complete, the excess hydrogel will appear to have thickened or solidified, and the 
excess can be removed from the brain. The use of tissue paper is recommended to remove as much excess hydro-
gel as possible. If the consistency of the hydrogel has not changed, unless very low concentrations of PFA and 
acrylamide are used, it is likely that hydrogel polymerisation has failed. The most likely issue is the pH of the PFA 
solution if it is made up in the laboratory. A neutral pH is required for polymerisation (7.4 is used successfully in 
our laboratory).
Once excess hydrogel was removed, the brain was incubated in clearing solution (SDS in in 0.2 M boric 
acid, pH = 8.5) whole, as hemispheres, or in 500 μm (using a vibratome, VT1000S, Leica Biosystems GmbH, 
Germany), 1.5 mm or 2 mm (using a brain-slicing matrix30) sections. Clearing buffer was exchanged after 24 and 
48 hours, and then weekly until samples became transparent. It is notably difficult to decide when to stop the 
clearing process, and tissue clarity eventually appears to plateau, leading to no changes from one week to the next. 
For this reason, the following rules were used:
•	 After the first 48 hours, only exchange clearing buffers (and therefore check clarity) every 7 days.
•	 Check tissue clarity in the same conditions such as in Fig. 1. Placing the samples in the same solution (e.g. 
clearing buffer) and on the same material (e.g. a backlit grid) greatly aids consistency in checking clarity.
•	 Stop clearing once the tissue does not obscure printed structures underneath.
•	 Compare the sample to other samples in the same study that have already been cleared for consistency.
In our laboratory, following these rules usually leads to all samples of the same type being cleared for the same 
length of time, and consistent staining and imaging quality. As long as the tissue is cleared to the point at which 
patterns can be seen through it without distortion (e.g. Fig. 1B) we do not observe any issues downstream with 
antibody staining.
After clearing, samples are washed in PBSTN3 (0.1% Tx100 and 0.01% sodium azide in PBS) for 48 hours 
(exchanging the solution twice per day) and stored until staining.
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tissue staining. Unless otherwise specified, primary antibody staining was carried out at the concentrations 
listed in Supplementary Table 2, made up in PBSTN3 for 7 days. The volume of antibody solution was also chosen 
to be at least five times larger than the volume of tissue (e.g. 1 ml for a 2 mm coronal mouse brain section). To 
speed up antibody penetration and ensure even staining, antibody incubation was performed with gentle shaking 
at 37 °C. Secondary antibody staining was performed in the exact same conditions, for the same length of time 
with the appropriate AlexaFluor 488 conjugated secondary antibody (Life Technologies Ltd, UK) but at a concen-
tration of 1:50. The use of a blocking agent (e.g. bovine serum albumin) has not shown any effect upon staining 
quality in cleared brain tissue, and so was not used.
Small molecule stains were also carried out in PBSTN3, but at room temperature (approximately 20 °C), and 
for 24 hours. All samples were thoroughly washed in PBSTN3 and then incubated in 85% glycerol in PBS for 
24 hours prior to imaging.
imaging and data analysis. Antibody and dye optimisation imaging was carried out on a variety of con-
focal and multiphoton microscopes. The comparison between cleared and uncleared tissue was carried out on a 
Nikon Eclipse 80i C1 laser-scanning confocal microscope (Nikon Instruments Europe BV, NL) using the param-
eters in Supplementary Table 5. All images in this section were 512 × 512 pixels and taken with a 150 μm pinhole.
All images were analysed using ImageJ37–40. Cell densities were determined manually and cortical thickness 
measurements were taken by measuring the length of straight lines drawn across the cortex. To measure cell vol-
umes, cells were segmented manually using the segmentation editor plugin41 and the volumes of the ROIs were 
calculated using the 3D ImageJ suite42. All image figures were generated using ImageJ and all statistics and plots 
were generated using Prism (Graphpad Software Inc, USA). In all cases, datapoints represent regions of interest, 
and not individual animals. Distributions were assessed for normality using the Shapiro-Wilk test and all were 
normal other than cortical CTIP2 cell counts in uncleared tissue. No analysis of correlation was performed to 
compare cleared and uncleared tissue. For ease of interpretation, all comparisons were carried out using the par-
ametric t-test. Due to the notable general reduction in variance for some variables in cleared tissue, Welch’s adap-
tation was used throughout (**p < 0.01, ***p < 0.001). Full test statistics are shown in Supplementary Table 6.
Data Availability
All raw data generated in the production of this manuscript is available on request.
References
 1. Spalteholz, W. Über das Durchsichtigmachen von menschlichen und tierischen Präparaten (Leipzig: Hirzel, 1914).
 2. Kuwajima, T. et al. ClearT: A detergent- and solvent-free clearing method for neuronal and non-neuronal tissue. Dev. 140, 
1364–1368, https://doi.org/10.1242/dev.091844 (2013).
 3. Tsai, P. S. et al. Correlations of neuronal and microvascular densities in murine cortex revealed by direct counting and colocalization 
of nuclei and vessels. The J. neuroscience 29, 14553–14570, https://doi.org/10.1523/JNEUROSCI.3287-09.2009 (2009).
 4. Ke, M., Fujimoto, S. & Imai, T. SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit 
reconstruction. Nat. neuroscience 16, 1154–1161, https://doi.org/10.1038/nn.3447 (2013).
 5. Hou, B. et al. Scalable and DiI-compatible optical clearance of the mammalian brain. Front. Neuroanat. 9, 1–11, https://doi.
org/10.3389/fnana.2015.00019 (2015).
 6. Aoyagi, Y., Kawakami, R., Osanai, H. & Hibi, T. A Rapid Optical Clearing Protocol Using 2, 2′-Thiodiethanol for Microscopic 
Observation of Fixed Mouse Brain. PLOS one 10, 1–13, https://doi.org/10.1371/journal.pone.0116280 (2015).
 7. Hama, H. et al. ScaleS: An optical clearing palette for biological imaging. Nat. Neurosci. 18, 1518–1529, https://doi.org/10.1038/
nn.4107 (2015).
 8. Ke, M. T. et al. Super-Resolution Mapping of Neuronal Circuitry With an Index-Optimized Clearing Agent. Cell Reports 14, 
2718–2732, https://doi.org/10.1016/j.celrep.2016.02.057 (2016).
 9. Steinke, H. & Wolff, W. A modified spalteholz technique with preservation of the histology. Annals Anat. 183, 91–95, https://doi.
org/10.1016/S0940-9602(01)80020-0 (2001).
 10. Dodt, H., Leischner, U. & Schierloh, A. Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse 
brain. Nat. methods 4, 331–336, https://doi.org/10.1038/NMETH1036 (2007).
 11. Ertürk, A. et al. Three-dimensional imaging of solvent-cleared organs using 3DISCO. Nat. protocols 7, 1983–1995, https://doi.
org/10.1038/nprot.2012.119 (2012).
 12. Becker, K., Jährling, N., Saghafi, S., Weiler, R. & Dodt, H. U. Chemical clearing and dehydration of GFP expressing mouse brains. 
PloS one 7, e33916, https://doi.org/10.1371/journal.pone.0033916 (2012).
 13. Pan, C. et al. Shrinkage-mediated imaging of entire organs and organisms using uDISCO. Nat. Methods 13, 859–867, https://doi.
org/10.1038/nmeth.3964 (2016).
 14. Jing, D. et al. Tissue clearing of both hard and soft tissue organs with the PEGASOS method. Cell Res. 23, 803–818, https://doi.
org/10.1038/s41422-018-0049-z (2018).
 15. Qi, Y. et al. FDISCO: Advanced solvent-based clearing method for imaging whole organs. Sci. Adv, https://doi.org/10.1126/sciadv.
aau8355 (2019).
 16. Hama, H. et al. Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain. Nat. 
neuroscience 14, 1481–1488, https://doi.org/10.1038/nn.2928 (2011).
 17. Chung, K. et al. Structural and molecular interrogation of intact biological systems. Nat. 497, 332–337, https://doi.org/10.1038/
nature12107 (2013).
 18. Susaki, E. A. et al. Whole-Brain Imaging with Single-Cell Resolution Using Chemical Cocktails and Computational Analysis. Cell 
157, 726–739, https://doi.org/10.1016/j.cell.2014.03.042 (2014).
 19. Tainaka, K. et al. Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents. Cell Reports 24, 2196–2210, https://doi.
org/10.1016/j.celrep.2018.07.056 (2018).
 20. Park, Y. G. et al. Protection of tissue physicochemical properties using polyfunctional crosslinkers. Nat. Biotechnol. 37, 73–83, 
https://doi.org/10.1038/nbt.4281 (2019).
 21. Yang, B. et al. Single-Cell Phenotyping within Transparent Intact Tissue through Whole-Body Clearing. Cell 158, 945–958, https://
doi.org/10.1016/j.cell.2014.07.017 (2014).
 22. Tomer, R., Ye, L., Hsueh, B. & Deisseroth, K. Advanced CLARITY for rapid and high-resolution imaging of intact tissues. Nat. 
Protoc. 9, 1682–1697, https://doi.org/10.1038/nprot.2014.123 (2014).
 23. Poguzhelskaya, E., Artamonov, D., Bolshakova, A., Vlasova, O. & Bezprozvanny, I. Simplified method to perform CLARITY 
imaging. Mol. neurodegeneration 9, 19, https://doi.org/10.1186/1750-1326-9-19 (2014).
1 0Scientific RepoRtS |         (2019) 9:12084  | https://doi.org/10.1038/s41598-019-48460-2
www.nature.com/scientificreportswww.nature.com/scientificreports/
 24. Lee, H., Park, J.-H., Seo, I., Park, S.-H. & Kim, S. Improved application of the electrophoretic tissue clearing technology, CLARITY, 
to intact solid organs including brain, pancreas, liver, kidney, lung, and intestine. BMC Dev. Biol. 14, 48, https://doi.org/10.1186/
s12861-014-0048-3 (2014).
 25. Costantini, I. et al. A versatile clearing agent for multi-modal brain imaging. Sci. Reports 5, 9808, https://doi.org/10.1038/srep09808 
(2015).
 26. Zheng, H. & Rinaman, L. Simplified CLARITY for visualizing immunofluorescence labeling in the developing rat brain. Brain 
Struct. Funct. 221, 2375–2383, https://doi.org/10.1007/s00429-015-1020-0 (2015).
 27. Epp, J. R. et al. Optimization of CLARITY for Clearing Whole-Brain and Other Intact Organs. eNeuro 2, 1–15, https://doi.
org/10.1523/ENEURO.0022-15.2015 (2015).
 28. Leuze, C. et al. The separate effects of lipids and proteins on brain MRI contrast revealed through tissue clearing. NeuroImage 156, 
412–422, https://doi.org/10.1016/j.neuroimage.2017.04.021 (2016).
 29. Sylwestrak, E. L. et al. Multiplexed Intact-Tissue Transcriptional Analysis at Resource Multiplexed Intact-Tissue Transcriptional 
Analysis at Cellular Resolution. Cell 164, 792–804, https://doi.org/10.1016/j.cell.2016.01.038 (2016).
 30. Tyson, A. L., Hilton, S. T. & Andreae, L. C. Rapid, simple and inexpensive production of custom 3D printed equipment for large-
volume fluorescence microscopy. Int. J. Pharm. 494, 651–656, https://doi.org/10.1016/j.ijpharm.2015.03.042 (2015).
 31. Morawski, M. et al. Developing 3d microscopy with clarity on human brain tissue: Towards a tool for informing and validating mri-
based histology. NeuroImage 182, 417–428, https://doi.org/10.1016/j.neuroimage.2017.11.060 Microstructural Imaging (2018).
 32. Harmsen, M. M. & De Haard, H. J. Properties, production, and applications of camelid single-domain antibody fragments. Appl. 
microbiology biotechnology 77, 13–22, https://doi.org/10.1007/s00253-007-1142-2 (2007).
 33. Kim, S. et al. Stochastic electrotransport selectively enhances the transport of highly electromobile molecules. Proc. Natl. Acad. Sci. 
E6274–E6283, https://doi.org/10.1073/pnas.1510133112 (2015).
 34. Li, J., Czajkowsky, D. M., Li, X. & Shao, Z. Fast immuno-labeling by electrophoretically driven infiltration for intact tissue imaging. 
Sci. Reports 5, 10640, https://doi.org/10.1038/srep10640 (2015).
 35. Wehrl, H. F. et al. Assessment of murine brain tissue shrinkage caused by different histological fixatives using magnetic resonance 
and computed tomography imaging. Histol. Histopathol. 30, 601–613, https://doi.org/10.14670/HH-30.601 (2015).
 36. Engberg, K. Journal articles, http://wiki.claritytechniques.org/index.php/Journal_Articles. [Online; accessed 6-August-2018].
 37. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675, https://
doi.org/10.1038/nmeth.2089 arXiv:1011.1669v3 (2012).
 38. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. methods 9, 676–682, https://doi.org/10.1038/
nmeth.2019 (2012).
 39. Schindelin, J., Rueden, C. T., Hiner, M. C. & Eliceiri, K. W. The ImageJ ecosystem: An open platform for biomedical image analysis. 
Mol. Reproduction Dev. 82, 518–529, https://doi.org/10.1002/mrd.22489 (2015).
 40. Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinforma. 18, 1–26, https://doi.
org/10.1186/s12859-017-1934-z 1701.05940 (2017).
 41. Schindelin, L., Kusztos, F., Schmid, B. Segmentation editor, https://imagej.net/Segmentation_Editor. [Online; accessed 
6-August-2018].
 42. Ollion, J., Cochennec, J., Loll, F., Escude, C. & Boudier, T. TANGO: a generic tool for high-throughput 3D image analysis for 
studying nuclear organization. Bioinforma. 29, 1840–1841, https://doi.org/10.1093/bioinformatics/btt276 (2013).
Acknowledgements
This work was supported by a Guy’s and St. Thomas’ Charity Prize PhD scholarship to A.L.T. and a BBSRC 
grant (BB/P000479/1) to L.C.A. We acknowledge financial support from the Innovative Medicines Initiative 
Joint Undertaking under grant agreement no. 115300, resources of which are composed of financial contribution 
from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind 
contribution, the Mortimer D Sackler Foundation and the Sackler Institute for Translational Neurodevelopment 
(A.L.T. and L.C.A.).
Author contributions
A.L.T. and L.C.A. conceived the experiments, A.L.T. and A.A. conducted the experiments and analysed the 
results, A.L.T. and L.C.A. wrote the manuscript. All authors reviewed the manuscript.
Additional information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-48460-2.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
